COMBINATION DRUG FOR PARENTERAL ADMINISTRATION CONTAINING METHYLETHYL PYRIDINOL HYDROCHLORIDE OR SUCCINATE AND RIBOFLAVIN

摘要

FIELD: medicine.;SUBSTANCE: preparation for parenteral administration contains a pharmaceutically acceptable salt of methylethyl pyridinol, which additionally contains riboflavin and has a composition, g/100 ml: methylethyl pyridinol hydrochloride or succinate 1.0-5.0; riboflavin 0.002-0.05; water for injections up to 100 ml.;EFFECT: improving properties.;3 cl, 3 ex, 1 tbl